NEW YORK, Sept 14 - Third Wave Technologies said Thursday it had reached an agreement to provide Imperial College of Great Britain, Royal Brompton's Hospital, and the UK National Health Service Trust with access to its Invader operating system for SNP detection and gene expression analysis.

Under the terms of the deal, Third Wave of Madison, Wis., will provide the institutions with preferred access to its pharmacogenomic assays as well as offer additional support for their genomics research.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.